Abstract
There is a pressing need for developing new anti-HIV agents due to the emergence of drug-resistant HIV mutants, side effects of existing drugs, and the mutation of the virus. High-throughput screening (HTS) has been proven as a powerful technique for the discovery of new anti-HIV drugs. The utilization of high-content screening (HCS) requires development of nanosensor that is suitable for HCS. We developed fluorescence imaging-based nanosensor for screening of inhibitors against activity of HIV-1 protease. We explored using AcGFP1 (a fluorescent mutant of the wild-type green fluorescent protein) and mCherry (a mutant of red fluorescent protein), as two fluorophores for Förster resonance energy transfer (FRET) microscopy imaging measurement of HIV-1 protease activity within living cells. Both in vitro and in vivo studies revealed that the novel molecular probes exhibit significant enhancement of FRET signals. The probe developed in this study enables HCS of new anti-HIV agents.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
P. Fortina, L.J. Kricka, S. Surrey, P. Grodzinski, Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol. 23(4), 168–173 (2005)
S. Jin, K. Ye, Nanoparticle-mediated drug delivery and gene therapy. Biotechnol. Prog. 23(1), 32–41 (2007)
M. Wolff, J. Wiedenmann, G.U. Nienhaus, M. Valler, R. Heilker, Novel fluorescent proteins for high-content screening. Drug Discov. Today. 11(23–24), 1054–1060 (2006)
A.E. Carpenter, Image-based chemical screening. Nat. Chem. Biol. 3(8), 461–465 (2007)
R.N. Ghosh, Y.T. Chen, R. DeBiasio, R.L. DeBiasio, B.R. Conway, L.K. Minor, K.T. Demarest, Cell-based, high-content screen for receptor internalization, recycling and intracellular trafficking. Biotechniques 29(1), 170–175 (2000)
D.L. Taylor, E.S. Woo, K.A. Giuliano, Real-time molecular and cellular analysis: the new frontier of drug discovery. Curr. Opin. Biotechnol. 12(1), 75–81 (2001)
Z. Li, Y. Yan, E.A. Powers, X. Ying, K. Janjua, T. Garyantes, B. Baron, Identification of gap junction blockers using automated fluorescence microscopy imaging. J. Biomol. Screen. 8(5), 489–499 (2003)
D.L. Almholt, F. Loechel, S.J. Nielsen, C. Krog-Jensen, R. Terry, S.P. Bjorn, H.C. Pedersen, M. Praestegaard, S. Moller, M. Heide et al., Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. Assay. Drug. Dev. Technol. 2(1), 7–20 (2004)
B. Liu, S. Li, J. Hu, Technological advances in high-throughput screening. Am. J. Pharmacogenomics. 4(4), 263–276 (2004)
M. Bickle, High-content screening: a new primary screening tool?. IDrugs 11(11), 822–826 (2008)
E.H. Mouchet, P.B. Simpson, High-content assays in oncology drug discovery: opportunities and challenges. IDrugs 11(6), 422–427 (2008)
T. Zal, Visualization of protein interactions in living cells. Adv. Exp. Med. Biol. 640, 183–197 (2008)
P. Kalab, J. Soderholm, The design of Forster (fluorescence) resonance energy transfer (FRET)-based molecular sensors for Ran GTPase. Methods 51(2), 220–232 (2010)
A. Masi, R. Cicchi, A. Carloni, F.S. Pavone, A. Arcangeli, Optical methods in the study of protein-protein interactions. Adv. Exp. Med. Biol. 674, 33–42 (2010)
A. Uri, M. Lust, A. Vaasa, D. Lavogina, K. Viht, E. Enkvist, Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors. Biochim. Biophys. Acta. 1804(3), 541–546 (2010)
M.C. Morris (2013) Fluorescent biosensors—probing protein kinase function in cancer and drug discovery. Biochim. Biophys. Acta. 1834, 1387–1395
D.K. Saini, N. Gautam, Live cell imaging for studying g protein-coupled receptor activation in single cells. Methods Mol. Biol. 617, 191–207 (2010)
M. Di Grandi, M. Olson, A.S. Prashad, G. Bebernitz, A. Luckay, S. Mullen, Y. Hu, G. Krishnamurthy, K. Pitts, J. O’Connell, Small molecule inhibitors of HIV RT Ribonuclease H. Bioorg. Med. Chem. Lett. 20(1), 398–402 (2010)
G. Dams, K. Van Acker, E. Gustin, I. Vereycken, L. Bunkens, P. Holemans, L. Smeulders, R. Clayton, A. Ohagen, K. Hertogs, A time-resolved fluorescence assay to identify small-molecule inhibitors of HIV-1 fusion. J. Biomol. Screen. 12(6), 865–874 (2007)
S. Jin, E. Ellis, J.V. Veetil, H. Yao, K. Ye Visualization of human immunodeficiency virus protease inhibition using a novel Forster resonance energy transfer molecular probe. Biotechnol. Prog. 27, 1107–1114 (2011)
H. Yao, S. Jin, Enhancement of probe signal for screening of HIV-1 protease inhibitors in living cells. Sensors 12(12), 16759–16770 (2012)
J. Lu, Z. Zhang, J. Yang, J. Chu, P. Li, S. Zeng, Q. Luo, Visualization of beta-secretase cleavage in living cells using a genetically encoded surface-displayed [corrected] FRET probe. Biochem. Biophys. Res. Commun. 362(1), 25–30 (2007)
F. Jeppsson, S. Eketjall, J. Janson, S. Karlstrom, S. Gustavsson, L.L. Olsson, A.C. Radesater, B. Ploeger, G. Cebers, K. Kolmodin et al., Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease. J. Biol. Chem. 287(49), 41245–41257 (2012)
Q. Lu, W.Y. Chen, Z.Y. Zhu, J. Chen, Y.C. Xu, M. Kaewpet, V. Rukachaisirikul, L.L. Chen, X. Shen, L655,240, acting as a competitive BACE1 inhibitor, efficiently decreases beta-amyloid peptide production in HEK293-APPswe cells. Acta. Pharmacol. Sinica. 33(12), 1459–1468 (2012)
M. Tramier, M. Zahid, J.C. Mevel, M.J. Masse, M. Coppey-Moisan, Sensitivity of CFP/YFP and GFP/mCherry pairs to donor photobleaching on FRET determination by fluorescence lifetime imaging microscopy in living cells. Microsc. Res. Tech. 69(11), 933–939 (2006)
L. Albertazzi, D. Arosio, L. Marchetti, F. Ricci, F. Beltram, Quantitative FRET analysis with the EGFP-mCherry fluorescent protein pair. Photochem. Photobiol. 85(1), 287–297 (2009)
N. Akrap, T. Seidel, B.G. Barisas, Forster distances for fluorescence resonant energy transfer between mCherry and other visible fluorescent proteins. Anal. Biochem. 402(1), 105–106 (2010)
J.V. Veetil, S. Jin, K. Ye, A glucose sensor protein for continuous glucose monitoring. Biosens. Bioelectron. 26(4), 1650–1655 (2010)
H. Takanaga, B. Chaudhuri, W.B. Frommer, GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim. Biophys. Acta. 1778(4), 1091–1099 (2008)
G.N. van der Krogt, J. Ogink, B. Ponsioen, K. Jalink, A comparison of donor-acceptor pairs for genetically encoded FRET sensors: application to the Epac cAMP sensor as an example. PloS One 3(4), e1916 (2008)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jin, S., Yao, H., Ellis, E. (2016). Fluorescent Nanosensor for Drug Discovery. In: Zhang, M., Naik, R., Dai, L. (eds) Carbon Nanomaterials for Biomedical Applications. Springer Series in Biomaterials Science and Engineering, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-319-22861-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-22861-7_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22860-0
Online ISBN: 978-3-319-22861-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)